Citadel Advisors
VASC

Citadel Advisors’s Vascular Solutions Inc VASC Stock Holding History

Citadel Advisors’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,000
Closed -$617K – 8511
2016
Q4 		$617K Buy
+11,000
New +$560K ﹤0.01% 4574
2016
Q1 		– Sell
-1,600
Closed -$55K – 8873
2015
Q4 		$55K Buy
1,600
+1,400
+700% +$47.4K ﹤0.01% 7242
2015
Q3 		$6K Sell
200
-4,600
-96% -$165K ﹤0.01% 8613
2015
Q2 		$167K Buy
4,800
+1,600
+50% +$52.2K ﹤0.01% 6542
2015
Q1 		$97K Sell
3,200
-500
-14% -$14.4K ﹤0.01% 6864
2014
Q4 		$100K Buy
3,700
+3,400
+1,133% +$92.3K ﹤0.01% 6634
2014
Q3 		$7K Sell
300
-500
-63% -$11.9K ﹤0.01% 7855
2014
Q2 		$18K Buy
800
+600
+300% +$13.1K ﹤0.01% 7361
2014
Q1 		$5K Buy
+200
New +$4.98K ﹤0.01% 7664

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Citadel Advisors's VASC Position: Q1 2017 in Review

Citadel Advisors sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 14,436 shares — an estimated $810K sold.

Citadel Advisors first reported a position in VASC in Q4 2013 and held it in 12 quarters. The position peaked at $1.24M in Q2 2015. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Citadel Advisors reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Citadel Advisors sold 14,436 Vascular Solutions Inc shares in Q1 2017, an estimated $810K.
  • Citadel Advisors first reported a position in Vascular Solutions Inc in Q4 2013 and held it in 12 quarters.
  • Citadel Advisors's Vascular Solutions Inc position peaked at $1.24M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.